Scientific Peptide Summary
KPV is a synthetically produced tripeptide composed of lysine, proline, and valine, corresponding to the terminal amino acid fragment of alpha-melanocyte stimulating hormone (α-MSH). Its concise structure and defined sequence make it a valuable compound for controlled laboratory investigations.
Cellular Interaction Profile
In experimental research settings, KPV has been evaluated for its role in intracellular signaling related to inflammatory modulation. In vitro models have explored its ability to penetrate cell membranes and influence molecular pathways associated with inflammatory responses and tissue repair mechanisms.
Research-Grade Production Standards
Manufactured in the United States under GMP-compliant conditions, KPV01 is produced to pharmaceutical-grade specifications. Each production lot is subjected to rigorous third-party analytical testing to confirm molecular identity, purity, sterility, and endotoxin compliance.
Technical Specifications
-
Sequence: Lys-Pro-Val
-
Molecular Weight: 342.43 g/mol
-
Molecular Formula: C16H30N6O4
-
CAS Number: 67727-97-3
-
PubChem CID: 125672
-
Synonyms: ACTH(11-13), α-MSH(11-13), MSH(11-13)
-
Purity: ≥98.5% (HPLC verified)
-
Form: White lyophilized powder
-
Solubility: Water soluble
-
Storage: −20°C, sealed, protected from heat and moisture
-
Shelf Life: 36 months under recommended conditions
Quality Control & Verification
All batches undergo independent laboratory testing to ensure compliance with strict research-use standards. This includes validation for sterility and endotoxin levels to support reproducibility and experimental accuracy.
Intended Research Use Only
KPV01 is supplied exclusively for in vitro research applications. It is not intended for human or veterinary use, clinical trials, diagnostics, or therapeutic purposes.
